-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Chlamydia trachomatis is a common bacterial sexually transmitted infection (STI) worldwide.
Infection Recently, researchers have carried out randomized, controlled trials to verify the treatment plan for rectal Chlamydia infection in gay men
This study was carried out in Australia.
antibiotic
625 male patients participated in the study, including 314 in the doxycycline group and 311 in the azithromycin group
In the intention-to-treat population, 281 (96.
Differences in microbiological cure rates between groups
According to the study, in the male homosexual population infected by chlamydia, the 7-day doxycycline treatment regimen is superior to the azithromycin regimen in terms of microbiological cure rate
In the male homosexual population with chlamydia rectal infection, the 7-day doxycycline treatment regimen is better than the azithromycin regimen in terms of microbiological cure rate.
Original source:
Andrew Lau et al.
Azithromycin or Doxycycline for Asymptomatic Rectal Chlamydia trachomatis.
Leave a message here